Cite
HARVARD Citation
Hourfar, K. et al. (2018). Human immunodeficiency virus 1 dual‐target nucleic acid technology improves blood safety: 5 years of experience of the German Red Cross blood donor service Baden‐Württemberg–Hessen. Transfusion. 58 (12), pp. 2886-2893. [Online].